About STRM.BIO
Based in Boston, MA, STRM.BIO (“storm bio”) is a pre-clinical, VC-backed biotechnology company that aims to fulfill the promise of gene therapy by leveraging extracellular vesicles (EVs) to deliver treatment directly to the patient (in vivo). Unlike viruses, EVs are natural carriers of nucleic acids and proteins with innate targeting capabilities, amenability to large scale/commercial manufacture, and low immunogenicity – which make them excellent cell messengers for gene therapies. Our proprietary EV platform is establishing a whole new class of therapeutics, yielding new therapies and making existing ones more effective. At STRM.BIO, we believe that our work has the potential to democratize gene therapy and bring hope for patients fighting rare diseases worldwide. We are currently recruiting team members who can help us make our vision a life-saving reality.
Founded in 2019 by Jonathan Thon.
- Founded
- 2019
- Employees
- 11 to 50
- Total funding
- $2.1M
- Headquarters
- Boston
Leadership
The top of STRM.BIO's org chart, with how many people report into each leader.
Jonathan Thon
Founder
11 reports
Sadettin Ozturk
Chief Technology Officer
7 reports
Eric Crombez
Chief Medical Officer, Ultragenyx Gene Therapy
Robert Hughes
Chief Financial Officer
David Raiser
Chief Operating Officer
Jobs at STRM.BIO
No open positions right now. Explore more companies on TheJobsMap.